EXCHANGE AGREEMENTExchange Agreement • April 13th, 2023 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionJeff Eliot Margolis (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on April 12, 2023, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series J 8% Voting, Participating, Redeemable Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).
EXCHANGE AGREEMENTExchange Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionJeff Eliot Margolis (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on September 30, 2020, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series H 2% Voting, Non-Participating, Convertible Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).
EXCHANGE AGREEMENTExchange Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionTimothy Lewis Jones (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on September 30, 2020, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series H 2% Voting, Non-Participating, Convertible Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).
EXCHANGE AGREEMENTExchange Agreement • October 14th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 14th, 2020 Company Industry JurisdictionArnold S. Lippa (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on September 30, 2020, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series H 2% Voting, Non-Participating, Convertible Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).
EXCHANGE AGREEMENTExchange Agreement • July 13th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2020 Company Industry JurisdictionArnold S. Lippa (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on July 13, 2020, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series H 2% Voting, Non-Participating, Convertible Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).
EXCHANGE AGREEMENTExchange Agreement • July 13th, 2020 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2020 Company Industry JurisdictionJeff Eliot Margolis (the “Employee”) enters into this Agreement (this “Agreement”) with RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”) on July 13, 2020, whereby Employee will exchange certain accrued compensation owed to the Employee by the Company for shares of Series H 2% Voting, Non-Participating, Convertible Preferred Stock, par value $0.001 (the “Preferred Stock”), of the Company (the “Exchange”).